Product Images Metformin Er 750 Mg

Each tablet contains 500 mg of metformin hydrochloride, USP. This medication comes in a package which includes a package insert for dosage information. Metformin Hydrochloride should be kept out of reach of children and stored at 20° to 25° C (68° to 77° F). Tablets should be dispensed in a light-resistant container along with patient information that is available at 5862207/ e 9 MO LIS. Manufactured by Granules India Limited, each package contains 100 tablets. This product is only available with a prescription.*

Metformin Hydrochloride is a medication used to treat type 2 diabetes. The package contains 500 tablets with a National Drug Code (NDC) number of 62207-491-47. Dosage information is provided in the enclosed package insert. The medication should be kept out of reach of children. The extended-release tablets should be stored at room temperature between 20-25°C (68-77°F), with excursions permitted within 16-30°C (69-86°F). The medication is manufactured by Granules India Limited and patient information is available on their website.*

This is a description of a medication with the NDC code 62207-491-49. The medication is Metformin Hydrochloride in Extended-Release formula and comes in a package of 1000 tablets, where each tablet contains 500 mg of metformin hydrochloride, USP. The dosage information is enclosed in the package insert. The medication should be kept out of reach of children and stored between 20°C to 25°C (68°F to 77°F), with certain excursions allowed. It should be dispensed in a light-resistant container with patient information available at a specified website. The medication was manufactured in India by Granules India Limited.*

This is a description of a medication with the National Drug Code 62207-491-54. The medication is Metformin Hydrochloride in the form of an extended-release tablet containing 500 mg of metformin hydrochloride. The package insert provides dosage information, and there is a warning to keep the medication out of the reach of children. The medication should be stored at 20° to 25° C (68° to 77° F), and dispensed in a light-resistant container with patient information available at a specific website. The medication is manufactured by Granules India Limited in Hyderabad, India.*

This is a description of Metformin Hydrochloride extended-release tablets. It contains 90 tablets with each tablet having 500mg of metformin hydrochloride, USP. Dosage information should be referred to the enclosed package insert. The tablets should be kept out of reach of children and stored in appropriate conditions between 20° to 26° C (68" to 77° F) with excursions permitted within 15° to 30° C (59° to 86° F). The tablets are dispensed in a light-resistant container along with patient information. This product is manufactured in India by Granules India Limited.*

This is a description of a medication called "Metformin Hydrochloride", which comes in the form of extended-release tablets. The package contains 100 tablets and each tablet has 750mg of metformin hydrochloride, USP. The dosage information is contained in the enclosed package insert. There is a warning to keep the medicine out of the reach of children and store it at a temperature of 20°C to 25°C (68°F to 77°F). The medication should be dispensed in a light-resistant container, and a patient information leaflet is available online. The medicine is manufactured by Granules India Limited in Hyderabad, India. The rest of the text seems to contain an expiration or batch code.*

This is a medication package containing 500 extended-release tablets of Metformin Hydrochloride, each tablet containing 750mg of the medication. Dosage and other information can be found in the package insert. The medication should be kept at a temperature of 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The package should be stored in a light-resistant container, and should be kept away from children. The medication is manufactured by Granules India Limited located in Hyderabad, India.*

This is a description of a medication with the following details: - Name: Metformin Hydrochloride Extended-Release Tablets, USP - Strength: 750 mg - Quantity: 1000 Tablets - Dosage: Refer to the package insert for dosage information. - Warning: Keep out of reach of children. - Storage: Store between 20°C to 25°C (68°F to 77°F). Excursions permitted within 15°C to 30°C (59°F to 86°F). Dispense in a light-resistant container. - Manufacturer: Granules India Limited, Hyderabad - 500 081, India - Country of origin: Made in India The indicated text does not include the details of the medication usage or indications.*

This is a medication package for Metformin Hydrochloride Extended-Release tablets with NDC number 62207-492-54. Each tablet contains 750mg of the medication. Dosage information can be found in the enclosed package insert. The medication should be kept out of reach of children and stored between 20°C to 25°C with excursions permitted between 15°C to 30°C. Dispense in a light-resistant container with patient information available at http:/www.granjilesindia.com/USProductCatalogphy. This medication is manufactured by Granules India Limited located in Hyderabad, India.*

This is a medication called Metformin Hydrochloride Extended-Release in the form of tablets. Each tablet contains 750mg of metformin Hydrochloride, and the enclosed package insert gives the dosage information. It should be kept out of the reach of children and stored between 20-25°C. It should be dispensed in a light-resistant container, and it's manufactured by Granules India Limited in Hyderabad, India. The patent information is available at 'https://www.granulesindia.com/U.SProductCatalog.php'.*

Metformin Hydrochloride Extended-Release Tablets USP, 750 mg is a medication for repacking purposes only. It is manufactured by Granules India Limited and batch number, number of units, manufacturing date, gross weight, expiry date, tare weight, manufacturing license number, net weight, NDC number, case number and product code are mentioned on the packaging. It is suggested to store the tablets in a light-resistant container at a temperature range of 20-25°C (68°-77° F) with excursions allowed from 15°-30° C (59°-86° F).*

Metformin Hydrochloride Extended-Release Tablets USP, 500 mg is a medication manufactured in India by Granules India Limited for Granules Pharmaceuticals Inc. The batch number is specified, along with the manufacturing and expiration date, and the product code. This medication is intended for repackaging only and must be stored between 20°-25° C (68°-77° F), with excursions permitted between 15°-30° C (59°-86° F). It is recommended to dispense this medication in light-resistant containers.*

Metformin Hydrochloride Extended-Release Tablets USP with a strength of 500 mg per tablet are present in this package. The batch number is XXXXXXX, and the number of units is 5x5,000. The manufacturing date is MM/YYYY, and the expiration date is MM/YYYY. The net weight is 00.000 kg, whereas the gross weight is 00.000 kg. The product is manufactured by Granules India Limited and distributed by Granules Pharmaceuticals Inc. It is recommended to store the tablets in a cool and dry place within the temperature range of 20°C-25°C. The tablets should be packed in light-resistant containers. The package code is XXXXXXXX. Other information related to repacking and caution statements are available. The product is made in India with no illegible characters on the package.*

Metformin Hydrochloride Extended-Release Tablets USP, 750mg is a medication produced in India by Granules India Limited and packaged by Granules Pharmaceuticals Inc. The batch number is not revealed. The tablets are contained in light-resistant containers for dispensing, with a recommended storage temperature condition of 20°-25°C(68°-77°F) and permissible excursions to 15°-30°C (59°-86°F). With only 3500 tablets available, the product's intended use appears to be for repacking purposes only. Although no specific use is specified, Metformin tablets are usually used to control high blood sugar levels caused by type 2 diabetes.*